7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Cancer Care

Medicines After a Bone Marrow Transplant: Anti-Rejection, Antivirals and What Blood Tests Track

22 min read
Medicines After a Bone Marrow Transplant: Anti-Rejection, Antivirals and What Blood Tests Track

Key Takeaways

  • After an allogeneic transplant, anti-rejection medicine mainly prevents graft-versus-host disease, in which donor immune cells attack the recipient, rather than classic organ rejection.
  • Calcineurin inhibitors such as tacrolimus need regular trough-level blood tests because azole antifungals, grapefruit and St. John's wort can push levels out of range within days.
  • Post-transplant cyclophosphamide is a planned part of GVHD prevention that removes reacting donor T cells; it does not signal that cancer has returned.
  • CMV, a herpes-family virus most adults carry silently, is either blocked with a preventive antiviral or tracked with weekly blood PCR so treatment can start before symptoms.
  • Autologous transplant recipients need no GVHD prevention, but still take anti-infective prophylaxis and must rebuild their vaccine protection from the beginning.
  • CDC guidance supports starting inactivated vaccines around six months after transplant and withholding live vaccines until at least two years have passed, immunosuppression has stopped and GVHD is inactive.
Quick Answer

After a bone marrow (stem cell) transplant, most people take a combination of immunosuppressants to prevent graft-versus-host disease, plus preventive antiviral, antifungal and antibiotic medicines while the new immune system matures. Regular blood tests track blood counts, kidney and liver function, drug levels and viral DNA such as CMV. Immunosuppression is usually tapered over months, and every change is decided by the transplant team.

The discharge nurse sets a weekly pill organizer on the bed, and it is not the small kind. Each compartment holds a different shape and color, and beside it sits a printed schedule with alarm times, a thermometer and a laminated card listing phone numbers for day and night. The person who arrived for the transplant three weeks ago thought the hard part was the chemotherapy. Now they are learning that the medicines after bone marrow transplant are, in many ways, the second half of the treatment.

That organizer is doing three jobs at once. One set of medicines keeps the new donor immune system from attacking its new home. Another holds old viruses and fungi at bay until the body can defend itself again. A third quietly supports the kidneys, the stomach and the gut while all of this happens.

This explainer walks through what each layer is for, how long people typically take it, what the blood tests are actually measuring, and when to pick up that laminated card and call.

What are medications after bone marrow transplant actually doing?

A bone marrow transplant, also called a hematopoietic stem cell transplant, replaces damaged or diseased blood-forming cells with healthy ones. The stem cells themselves arrive through a central line in a bag that looks like an ordinary transfusion. The dramatic part happens before and after that bag.

Before infusion, conditioning treatment (high-dose chemotherapy, sometimes with radiation) clears out the existing marrow and suppresses the recipient’s immune system so the graft can take hold. According to Mayo Clinic, the new cells then travel to the marrow and begin producing blood cells over a period of weeks, a step called engraftment. Until that happens, the body has almost no neutrophils, the white blood cells that fight bacteria and fungi.

Medicines fill the gaps that conditioning creates. Think of them as scaffolding around a building under construction:

  • Immunosuppressants calm the donor’s T cells, a type of white blood cell that would otherwise recognize the recipient’s tissues as foreign.
  • Antivirals, antifungals and antibiotics stand in for an immune system that cannot yet respond on its own.
  • Supportive medicines protect organs under strain: anti-nausea drugs, stomach-acid reducers, medicines to replace magnesium or potassium, and sometimes growth factors that nudge white cell production.

Nothing in that list is permanent by design. As the National Cancer Institute explains, the goal is a graft that settles in, learns to tolerate its host and eventually defends it, at which point the scaffolding comes down piece by piece. The order in which it comes down, and how fast, is set by the transplant team based on what the blood tests show, not by the calendar alone.

Why is it called anti-rejection medicine when the graft does the attacking?

In a kidney or liver transplant, the recipient’s immune system attacks the donated organ. That is rejection, and the medicines are rightly called anti-rejection drugs. A stem cell transplant turns the picture around. The donor cells become the immune system, and the main risk is that they attack the recipient. This is graft-versus-host disease, usually shortened to GVHD.

Doctor consulting patient holding medication bottle: Why is it called anti-rejection medicine when the graft does the attack

MedlinePlus describes GVHD as a reaction in which the donor’s immune cells treat the recipient’s skin, gut and liver as foreign tissue. Acute GVHD tends to appear in the first months and shows up as a rash, diarrhea or jaundice. Chronic GVHD can develop later and may affect the eyes, mouth, skin, joints and lungs over a longer time.

Rejection in the kidney-transplant sense, where the recipient’s leftover immune cells reject the graft, can happen after stem cell transplant too, but it is less common because conditioning has already suppressed those cells. So when transplant teams talk about immunosuppressants, GVHD prevention is almost always what they mean, and the phrase anti-rejection drugs after stem cell transplant is a convenient shorthand rather than a precise description.

There is a twist that matters. The same donor immune activity that causes GVHD can also attack any remaining cancer cells, an effect called graft-versus-leukemia or graft-versus-tumor. The National Cancer Institute notes this is one reason allogeneic (donor) transplants are used for certain blood cancers. Immunosuppression therefore walks a line: enough to prevent dangerous GVHD, not so much that the graft loses its ability to police the marrow. That balance explains why teams taper slowly and watch closely rather than simply maximizing suppression.

Which immunosuppressant classes are used, and how does each one work?

Most prevention plans combine two or more classes, each interrupting a different step in the T-cell attack. Names below are generic and listed to explain mechanism, not as recommendations; the regimen is chosen by the transplant team.

Calcineurin inhibitors (tacrolimus, cyclosporine) block an enzyme that T cells need to switch on. They form the backbone of many regimens and require regular blood-level monitoring because the window between too little and too much is narrow. Both can affect kidney function, blood pressure and magnesium levels, which is why those appear on the lab sheet.

Antimetabolites (methotrexate in short courses around the transplant, or mycophenolate) slow the division of rapidly multiplying immune cells.

Post-transplant cyclophosphamide is a chemotherapy drug given in the days after the stem cells arrive. It preferentially eliminates the donor T cells that are actively reacting against the recipient while sparing the resting ones. If you have read about a common chemotherapy drug being used after a blood stem cell transplant, this is what is meant, and it is not a sign the cancer has returned.

mTOR inhibitors (sirolimus) block a signaling pathway cells use to grow and multiply.

Antithymocyte globulin, an antibody preparation, is sometimes given during conditioning to deplete T cells before the graft arrives.

Corticosteroids are typically reserved for treating GVHD once it appears rather than for routine prevention, because of their effects on blood sugar, bone, mood and infection risk.

Which combination a person receives depends on the donor type, the disease, age and organ function. Changing or stopping any of them without the team’s instruction can trigger GVHD that is harder to control than the original risk.

How long do people take anti-rejection drugs after stem cell transplant?

The honest answer is that there is a typical shape but no fixed number. Immunosuppression usually begins shortly before the stem cells are infused and continues at a steady level through the early months while the graft settles. If no significant GVHD appears, teams generally begin a gradual taper during the first several months and aim to finish within roughly the first year. People who develop chronic GVHD may stay on treatment far longer, sometimes for years, with periods of adjustment as symptoms flare and settle.

Doctor consulting with older male patient about medication: How long do people take anti-rejection drugs after stem cell tra

Why the slow fade rather than a clean stop? A taper lets the team watch for early GVHD signs at each step and pause or reverse if needed. It also gives the donor immune system time to develop tolerance, the state in which it recognizes the recipient’s tissues as self. The NHS describes the overall immune recovery after transplant as taking a year or more, and the taper roughly mirrors that timeline.

Several things commonly lengthen the course:

  • Any episode of acute GVHD, which usually resets the clock and may add corticosteroids.
  • Mixed chimerism, meaning blood tests show both donor and recipient cells still present, which may prompt a faster taper in some protocols or a slower one in others.
  • Relapse concerns, where teams may deliberately reduce immunosuppression sooner to strengthen the graft-versus-tumor effect.

Autologous transplant recipients, whose own stored cells are returned to them, do not need GVHD prevention at all, because the graft is not foreign. Their medicine list is shorter and centers on infection prevention. Whatever the pathway, how long immunosuppressants continue after transplant is a decision the prescribing clinician revisits at nearly every visit, guided by the labs discussed below.

Antivirals, antifungals and antibiotics: the preventive layer

A newly transplanted immune system is like a city with its police force in training. Infections that a healthy adult shrugs off can become serious, so the team prescribes preventive medicines rather than waiting for symptoms. This is prophylaxis: medicine taken to stop an infection before it starts.

Cytomegalovirus (CMV) is the virus transplant teams talk about most. It is a common herpes-family virus that most adults carry silently for life. After transplant it can reactivate and inflame the lungs, gut or eyes. Teams either give a preventive antiviral (letermovir is one example that blocks the virus’s ability to package its DNA) or monitor CMV DNA in the blood weekly and start treatment if levels rise. Which approach is used depends on whether the donor and recipient carry the virus.

Herpes simplex and varicella-zoster (the shingles virus) are suppressed with antivirals of the acyclovir class, which block viral DNA copying. This commonly continues for a year or longer because shingles risk stays elevated while T cells recover.

Pneumocystis, a fungus that causes a severe pneumonia in people with weak immunity, is prevented with an antibiotic combination such as trimethoprim-sulfamethoxazole or an alternative if that is not tolerated.

Molds and yeasts are covered by antifungal azoles during the neutropenic weeks and for longer if GVHD treatment is needed. Azoles are notorious for raising calcineurin inhibitor levels, a point that comes up again under interactions.

Each of these has an off-ramp tied to a lab marker: neutrophil recovery, CD4 T-cell counts, time off immunosuppression or a run of negative CMV results. The off-ramp is the team’s call.

Blood tests after bone marrow transplant: what each result is tracking

Early on, blood is drawn several times a week, then weekly, then at longer intervals. It can feel excessive. Each tube, though, answers a specific question about the graft, the organs or the medicines.

Test What it measures Why it matters after transplant
Complete blood count Red cells, white cells (especially neutrophils), platelets Confirms engraftment and tells the team when infection and bleeding risk are falling
Kidney function (creatinine, eGFR) How well the kidneys filter Calcineurin inhibitors and some antivirals can strain the kidneys
Liver tests (bilirubin, ALT, AST) Liver inflammation and bile flow Early clue to liver GVHD, drug toxicity or a liver complication of conditioning
Electrolytes (magnesium, potassium) Mineral balance Tacrolimus and cyclosporine commonly lower magnesium; supplements are adjusted to results
Drug trough levels Immunosuppressant concentration just before the next dose Keeps the level in the protective range while limiting side effects
CMV and other viral PCR Viral DNA in blood Detects reactivation days before symptoms
Chimerism Percentage of blood cells that are donor-derived Shows whether the graft is fully taking over
Immunoglobulins and lymphocyte subsets Antibody levels and T-cell counts Guides when preventive medicines and vaccines can start or stop
Glucose, lipids Blood sugar and cholesterol Corticosteroids and some immunosuppressants raise both

A trough level is simply a blood draw timed right before a dose, when the drug is at its lowest. That is why clinics ask people to hold the morning dose until after the sample. A result outside range does not mean something went wrong; it is the signal that lets the team adjust before a problem appears.

Who is usually on which plan, and who is asked to wait

Two people can leave the same transplant unit with very different pill organizers. The differences follow a few predictable lines.

Autologous versus allogeneic. Someone receiving their own cells (common for myeloma and some lymphomas) has no GVHD risk, so no immunosuppressants. They still take antiviral, antifungal and pneumocystis prevention while counts recover, generally for a shorter stretch.

Donor match. A fully matched sibling or unrelated donor usually means a calcineurin inhibitor plus an antimetabolite. A half-matched (haploidentical) family donor, or a mismatched unrelated donor, is more likely to involve post-transplant cyclophosphamide followed by two further agents, because the immune mismatch is larger.

CMV status. If either donor or recipient carries CMV, preventive antiviral or intensive monitoring is added. If both are negative, the plan may rely on monitoring alone.

Organ function. People with reduced kidney function may receive an mTOR inhibitor instead of a calcineurin inhibitor, or closer level monitoring.

Who is asked to wait?

  • Anyone with active GVHD waits to taper immunosuppression until symptoms are controlled.
  • Live vaccines wait, per CDC guidance, until at least two years have passed, immunosuppression has stopped and there is no active GVHD.
  • Stopping shingles prevention waits for a defined period off immunosuppression and adequate T-cell recovery.
  • Returning to work, travel or crowded settings is usually delayed until neutrophils are reliably recovered and the team is comfortable with infection risk.

Waiting is not a setback. It is the team reading the labs and choosing the safer sequence. Asking why a particular step is on hold usually yields a specific, reassuring answer.

What the first weeks and months usually look like

Transplant teams count time from day zero, the day the cells are infused. The medicine plan follows that count more than the calendar.

Days 0 to about 14: the neutropenic phase. Blood counts are at their lowest. Antibiotics, antifungals and antivirals are given, often intravenously. Immunosuppressants are already running. Mouth sores and nausea from conditioning peak, so pain relief and anti-nausea medicines are prominent. Fevers are common and are treated promptly as potential infections.

Engraftment: typically within a few weeks. Mayo Clinic describes new blood cells appearing over a period of weeks; the first sign is usually a rising neutrophil count. Growth factor injections, if used, stop. Intravenous medicines are switched to oral ones in preparation for discharge.

The first 100 days. Many programs keep patients close to the center with visits two or three times a week. This is the window for acute GVHD and early CMV reactivation, so trough levels and viral PCRs are frequent. Mild rashes and loose stools are reported the same day rather than watched at home.

Months 3 to 12. If GVHD has not appeared, immunosuppression tapers. Visits spread out. Around six months, CDC guidance supports starting the inactivated vaccine series. Pneumocystis and antifungal prevention typically ends when immunosuppression stops; shingles prevention often continues longer.

Beyond a year. The NHS notes recovery can take a year or more. Chronic GVHD surveillance, bone health, skin checks and heart-risk screening become the focus, and the pill organizer, for many people, grows noticeably lighter.

These are typical ranges, not promises. Infections, GVHD or slow engraftment can shift any stage, and the team adjusts the plan accordingly.

Drug interactions, food and supplements: why the team asks about everything

The pharmacist’s question, “Anything else you are taking, including vitamins or herbal products?”, is not a formality. Calcineurin inhibitors and mTOR inhibitors are processed by a liver enzyme system that many common substances speed up or slow down, and a shift in either direction can move drug levels out of range within days.

Substances that can raise levels include azole antifungals (often prescribed deliberately, with the immunosuppressant adjusted in tandem), some antibiotics, certain blood pressure medicines and grapefruit or grapefruit juice. Higher levels mean more kidney strain, tremor and high blood pressure.

Substances that can lower levels include St. John’s wort, some anti-seizure medicines and certain tuberculosis antibiotics. Lower levels mean less protection against GVHD.

Over-the-counter products deserve the same scrutiny. Nonsteroidal anti-inflammatory painkillers add to kidney stress when combined with a calcineurin inhibitor. Antacids and some stomach medicines can change how other drugs are absorbed. Herbal immune boosters are a particular concern because the entire point of the regimen is to keep immunity in check.

Food matters in two ways. Some immunosuppressants are absorbed differently with or without food, so consistency with meals is often advised. Food safety matters more: undercooked meat, unpasteurized dairy, raw sprouts and unwashed produce carry bacteria and parasites that a recovering immune system cannot handle well.

None of this means a long list of forbidden items to memorize. It means one habit: before adding anything, prescription or not, run it past the transplant pharmacist or clinician. They can check it in minutes, and that is far easier than correcting a drug level that has drifted.

Vaccines after transplant: rebuilding immunity from the beginning

Conditioning does not only clear the marrow. It wipes out much of the immune memory built up over a lifetime, including protection from childhood vaccines. The donor’s immune memory does not transfer reliably either. In practical terms, a transplant recipient becomes, immunologically, something like a newborn, and a vaccine schedule is rebuilt from the beginning.

CDC guidance on vaccinating people with altered immunocompetence outlines the broad pattern. Inactivated (non-live) vaccines generally begin around six months after transplant, when the new immune system can start to form antibodies. These include vaccines against pneumococcus, tetanus, diphtheria, pertussis, polio, Haemophilus influenzae type b, hepatitis B, meningococcus, influenza (given yearly, sometimes starting earlier during flu season) and COVID-19. Several require multiple doses spaced over months because the response builds slowly.

Live vaccines, such as measles-mumps-rubella and varicella, are a different matter. Because they contain weakened but living virus, they can cause illness in someone with suppressed immunity. CDC guidance holds them until at least two years after transplant, and only if the person is off immunosuppression and free of active GVHD. Some teams also check antibody levels before deciding.

Family and close contacts are part of the plan. Their annual influenza vaccine and up-to-date routine vaccines reduce the chance of carrying infection into the house. One exception is the oral live vaccines once used in some countries; contacts are generally advised to receive inactivated versions where a choice exists.

Vaccine timing is individualized. GVHD treatment, intravenous immunoglobulin infusions and low lymphocyte counts can all delay a dose. The schedule lives with the transplant team, and it is reasonable to ask for a written copy to share with a primary care clinician.

What precautions should I take after a bone marrow transplant?

The precautions after bone marrow transplant that teams emphasize are less about isolation and more about removing the avoidable risks while medicines do the rest. The NHS and MedlinePlus describe a similar core set.

Infection avoidance. Hand washing before eating and after being in public is the single most repeated instruction. Crowded indoor spaces, people with colds and children recently given live vaccines are avoided in the early months. Masks are commonly advised in clinics and on public transport while counts recover.

Food and water. Cook meat and eggs thoroughly, avoid unpasteurized products and raw sprouts, wash produce well, and follow the team’s advice on tap water if there are concerns about local supply.

Home and outdoors. Soil, compost, construction dust and stagnant water carry molds. Gardening, cleaning litter boxes or bird cages and renovation work are usually off the list at first. Pets can generally stay, with someone else handling waste.

Skin and sun. Sun exposure can trigger skin GVHD and raises long-term skin cancer risk after conditioning. Protective clothing and broad-spectrum sunscreen become lifelong habits.

Central line care. While a line is in place, keep the dressing clean and dry and report redness, pain or fever immediately.

Sexual health and fertility. Barrier protection is advised while on immunosuppression. Conditioning often affects fertility, and contraception is still recommended because pregnancy would carry high risk during treatment; the team can discuss options.

Alcohol and smoking. Both stress the liver and lungs that are already under watch, and alcohol interacts with several medicines. Teams generally advise avoiding alcohol at least while on immunosuppression.

Precautions loosen as labs improve. Asking at each visit which restrictions still apply keeps the list current rather than permanent.

What people often get wrong about medicines after bone marrow transplant

“Feeling well means I can stop.” GVHD and viral reactivation can be silent for days before symptoms appear. The medicines are preventing problems that have not happened yet, so feeling fine is evidence they are working, not that they are unnecessary.

“Anti-rejection drugs suppress the whole immune system forever.” They suppress specific pathways, and for most people without chronic GVHD they taper off within the first year or so. Lifelong immunosuppression is the exception, not the rule.

“A chemotherapy drug after transplant means the cancer is back.” Post-transplant cyclophosphamide is part of GVHD prevention. It targets reacting donor T cells, not cancer, and is planned before the transplant takes place.

“The transplant itself is painful.” The infusion is a line infusion and is not painful. Discomfort comes from conditioning side effects such as mouth sores, nausea and fatigue, and from the donor’s harvest if marrow is collected from the pelvis under anesthesia. Pain is managed actively throughout.

“Autologous transplant means no medicines afterwards.” There is no GVHD prevention, but anti-infective prophylaxis and vaccine rebuilding still apply.

“Supplements are harmless because they are natural.” St. John’s wort can lower immunosuppressant levels enough to risk GVHD, and immune-boosting herbs work against the regimen’s purpose.

“Once I am off everything, follow-up ends.” Chronic GVHD, late infections, bone thinning, heart risk and second cancers are monitored for years. The pill organizer empties long before the clinic visits stop.

“A high or low drug level means I did something wrong.” Levels drift with diarrhea, new medicines, illness and changing kidney function. That is precisely why they are checked.

Questions to ask your care team about your transplant medicines

Transplant visits are dense, and the most useful questions are the ones that help you understand the plan rather than second-guess it. Bringing a written list and a second set of ears helps.

About the immunosuppressants

  • Which medicines are preventing GVHD, and what is the current plan and rough timeline for tapering them?
  • What early signs of GVHD should I report the same day?
  • Which of my lab results tell you the level is right, and what range are you aiming for?

About infection prevention

  • Am I on preventive CMV medicine or on weekly monitoring, and why that choice for me?
  • Which of these medicines will stop first, and what result triggers stopping?
  • When should my vaccine series start, and can I have a written schedule for my primary care clinician?

About daily life

  • Which foods, drinks or activities interact with my specific medicines?
  • If I vomit or have diarrhea after taking a dose, what should I do, and whom do I call?
  • Which over-the-counter medicines are safe for a headache, a cold or heartburn?
  • When can I expect restrictions on crowds, work or travel to loosen?

About monitoring

  • How often will blood be drawn over the next month, and does the timing matter relative to my doses?
  • What does my chimerism result mean, and does it change the plan?
  • Who is my point of contact for medicine questions between visits, and what are the after-hours arrangements?

Write the answers down. A plan that is understood is a plan that is followed accurately, and accuracy is what keeps drug levels steady between visits.

When to call your doctor: red-flag signs after a bone marrow transplant

Transplant teams would rather hear from you ten times about nothing than once too late. The laminated card with the day and night numbers exists because several complications move quickly in someone whose immune defenses are suppressed. Use it without hesitation for any of the following.

Call immediately, day or night:

  • A temperature at or above the threshold your team set, usually around 38°C (100.4°F), even once, with or without chills. Fever during the neutropenic phase is treated as an emergency, as MedlinePlus and the NHS both emphasize.
  • Shortness of breath, a new cough or chest pain.
  • Bleeding that does not stop, blood in stool or urine, or widespread bruising and pinpoint red spots.
  • A new rash, especially on the palms, soles, ears or neck, or a spreading rash anywhere.
  • Diarrhea that is frequent, watery or bloody, or severe abdominal pain.
  • Yellowing of the skin or eyes, or dark urine.
  • Confusion, severe headache, seizure, or sudden weakness.
  • Redness, swelling, pain or discharge at the central line site.
  • Vomiting that prevents you from keeping medicines down, or a missed dose you are unsure how to handle.

Call the same day: new mouth sores or difficulty swallowing, painful or blurred vision, blisters or burning on one side of the body (possible shingles), swelling of the legs, a sudden drop in urine output, or any new medicine another clinician wants to start.

None of these signs means the transplant has failed. Most have a specific, treatable cause when caught early. The judgment about what they mean, and whether any medicine needs to change, belongs to the transplant team. Your job is simply to make the call.

Frequently asked questions

How long do you take immunosuppressants after a bone marrow transplant?

Most people without significant graft-versus-host disease begin tapering immunosuppression in the first several months and finish within about the first year, though the exact course is set by the transplant team. Chronic GVHD can extend treatment for years. Tapering is gradual so that early GVHD signs can be caught at each step, and the NHS notes overall immune recovery can take a year or more.

What blood tests are done after a bone marrow transplant, and why so often?

Routine panels include a complete blood count to confirm engraftment, kidney and liver tests, electrolytes such as magnesium, immunosuppressant trough levels, viral PCR for CMV, and chimerism to show what share of blood cells are donor-derived. Early on they are drawn several times a week because drug levels, infection risk and GVHD can change quickly; frequency falls as results stabilize.

What can a bone marrow transplant treat?

Stem cell transplants are used for blood cancers such as leukemias, lymphomas and myeloma, for marrow failure conditions including aplastic anemia and myelodysplastic syndromes, and for certain inherited blood and immune disorders such as sickle cell disease, thalassemia and severe immunodeficiencies. The National Cancer Institute and MedlinePlus list these indications. Whether transplant is appropriate for an individual depends on the disease, its stage, age, organ function and donor availability.

What are the common chemotherapy treatments for MDS?

Myelodysplastic syndromes are often treated with a class called hypomethylating agents (azacitidine and decitabine are the generic examples), which alter how genes in abnormal marrow cells are switched on and off. Higher-risk disease in fit patients may involve intensive leukemia-style chemotherapy, sometimes as a bridge to transplant. Supportive care with transfusions or growth factors is also common. The choice depends on risk category and is made by the treating hematologist.

Is it painful to have a bone marrow transplant?

The stem cell infusion itself is not painful; it runs through a central line much like a transfusion. Discomfort comes mainly from conditioning chemotherapy, which can cause mouth sores, nausea, diarrhea and fatigue, and these are actively treated. Donors who give marrow from the pelvis do so under anesthesia and may have aching for several days. Pain control is a standard part of the care plan throughout.

What precautions should I take after a bone marrow transplant at home?

Core precautions are frequent hand washing, avoiding crowded indoor spaces and people who are unwell, careful food safety (thoroughly cooked meat and eggs, no unpasteurized products or raw sprouts), staying away from soil, compost and construction dust, protecting skin from sun, keeping any central line clean and dry, and checking every new medicine or supplement with the transplant pharmacist. Restrictions ease as blood counts recover.

Why am I taking a chemotherapy drug after my stem cell transplant?

Cyclophosphamide given in the days after infusion is part of graft-versus-host disease prevention, not cancer treatment. It preferentially eliminates donor T cells that are actively reacting against your tissues while sparing resting cells that will later form your new immune system. It is planned before transplant, particularly with half-matched or mismatched donors, and is followed by other immunosuppressants.

What is CMV and why does my transplant team keep testing for it?

Cytomegalovirus is a common herpes-family virus that most adults carry without symptoms. After transplant, suppressed immunity lets it reactivate and inflame the lungs, gut, liver or eyes. Teams either prescribe a preventive antiviral or run weekly blood PCR tests that detect viral DNA days before symptoms, starting treatment if levels rise. Which approach is used depends on whether donor and recipient carry the virus.

Can I drink grapefruit juice or take herbal supplements on anti-rejection drugs?

Grapefruit and grapefruit juice can raise calcineurin inhibitor levels, increasing kidney strain and other side effects, so they are usually avoided. St. John’s wort can lower levels enough to risk graft-versus-host disease. Many other herbal products have unknown interactions, and immune-boosting supplements work against the regimen’s purpose. Ask the transplant pharmacist before adding anything, including vitamins and over-the-counter remedies.

What should I do if I miss a dose or vomit after taking my transplant medicine?

Contact your transplant team the same day rather than guessing. Do not take an extra dose to make up for a missed one unless they tell you to, because immunosuppressant levels are kept in a narrow range. Vomiting or diarrhea can change absorption, so the team may bring a blood level forward. Most programs provide a day and night number precisely for questions like this.

References

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Dr. Şule Eren
Dr. Şule Eren, MD
Author
View profile →
Published November 20, 2026
Keep Reading

More from the Blog

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.